320 related articles for article (PubMed ID: 23339695)
1. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
Omran OM
J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
[TBL] [Abstract][Full Text] [Related]
2. CD10 expression in tumour and stromal cells of bladder carcinoma: an association with bilharziasis.
Abdou AG
APMIS; 2007 Nov; 115(11):1206-18. PubMed ID: 18092952
[TBL] [Abstract][Full Text] [Related]
3. CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer.
Omran OM; Ata HS
Ultrastruct Pathol; 2012 May; 36(3):145-52. PubMed ID: 22559040
[TBL] [Abstract][Full Text] [Related]
4. Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.
Hussien MT; Helmy E; Elsaba TM; Elkady A; Alrefai H; Hetta HF
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1573-1583. PubMed ID: 32592351
[TBL] [Abstract][Full Text] [Related]
5. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
[TBL] [Abstract][Full Text] [Related]
6. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
Youssef MY; Mohamed MA
Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions.
Ahmed AR; Muhammad EM
J Egypt Natl Canc Inst; 2014 Dec; 26(4):211-7. PubMed ID: 25282623
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 protein in bilharzial and non-bilharzial bladder cancers.
Gadalla HA; Kamel NA; Badary FA; Elanany FG
BJU Int; 2004 Jan; 93(1):151-5. PubMed ID: 14678388
[TBL] [Abstract][Full Text] [Related]
9. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression in urinary bladder transitional cell carcinoma and its association with clinicopathological characteristics.
Tabriz HM; Olfati G; Ahmadi SA; Yusefnia S
Asian Pac J Cancer Prev; 2013; 14(8):4539-43. PubMed ID: 24083698
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma of the bilharzial bladder in Egypt. Clinical and pathological features.
el-Boulkany MN; Ghoneim MA; Mansour MA
Br J Urol; 1972 Oct; 44(5):561-70. PubMed ID: 5084827
[No Abstract] [Full Text] [Related]
12. Expression of CD10 in urothelial carcinoma of the bladder and its correlation with histopathological grade, pathological stage, and survival of patients.
Shukla SK; Chandra S; Chauhan N; Sarpal R
J Cancer Res Ther; 2021; 17(4):887-892. PubMed ID: 34528537
[TBL] [Abstract][Full Text] [Related]
13. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
[TBL] [Abstract][Full Text] [Related]
16. Staging of carcinoma of bilharzial bladder.
Ghoneim MA; Mansour MA; el-Bolkainy MN
Urology; 1974 Jan; 3(1):40-2. PubMed ID: 4812896
[No Abstract] [Full Text] [Related]
17. Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10.
Kumagai-Togashi A; Uozaki H; Kikuchi Y; Watabe S; Numakura S; Watanabe M
Anticancer Res; 2019 Feb; 39(2):635-640. PubMed ID: 30711939
[TBL] [Abstract][Full Text] [Related]
18. Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients.
Rady M; Mostageer M; Rohde J; Zaghloul A; Knüchel-Clarke R; Saad S; Attia D; Mahran L; Spahn-Langguth H
Oncol Rep; 2017 Jul; 38(1):551-560. PubMed ID: 28586062
[TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients.
Ikegami H; Iwasaki H; Ohjimi Y; Takeuchi T; Ariyoshi A; Kikuchi M
Hum Pathol; 2000 Mar; 31(3):332-40. PubMed ID: 10746676
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.
Ross JS; Cheung C; Sheehan C; del Rosario AD; Bui HX; Fisher HA
Diagn Cytopathol; 1996 Jun; 14(4):310-5. PubMed ID: 8725130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
